๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Danazol therapy for aplastic anemia refractory to immunosuppressive therapy

โœ Scribed by Tatsuya Chuhjo; Hirohito Yamazaki; Mitsuhiro Omine; Shinji Nakao

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
67 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Recombinant Interleukin-1 Followed by im
Recombinant Interleukin-1 Followed by immunosuppressive therapy for aplastic anemia
โœ Kristine Doney; Rainer Store; Kathy Lilleby; Frederick R. Appeleaum ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB

A survay of 214 non-hemophilic patients with inhibitors to 2. Green D: Suppression of an antibody to factor VlII by a combination of factor 3. Ting HC, Wang F, Por P, Nurulhuda A: Idiopathic Inhibitor of factor VIlI and its 4. Green D: Immunosuppression of factor VIII inhibitors in nonhemophilic pat

Ticlopidine-induced aplastic anemia: Dev
Ticlopidine-induced aplastic anemia: Development of chromosomal abnormalities and response to immunosuppressive therapy
โœ Pullarkat, Vinod A.; Rho, Hyan; Murata-Collins, Joyce L.; Liebman, Howard A. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 49 KB ๐Ÿ‘ 2 views

Severe aplastic anemia is a well-recognized complication of ticlopidine therapy that carries a high mortality. Therapy with colony-stimulating factors or corticosteroids has been largely ineffective in this disorder. We report a case of ticlopidine-induced aplastic anemia that was successfully treat